Central administration of kisspeptin-10 inhibits natriuresis and diuresis induced by blood volume expansion in anesthetized male rats.
Han. Xu X; Yan. Ming M; An. Xiao-fei XF; He. Ming M; Yu. Jiang-yi JY
Key Findings
- Central kisspeptin-10 injection blocks volume‑expansion‑induced natriuresis and diuresis in rats
- The blockage coincides with a rise in plasma vasopressin (AVP)
- The effect occurs without changes in atrial natriuretic peptide (ANP) or renal sympathetic nerve activity
Practical Outcomes
- The study shows kisspeptin can influence water‑salt balance via the brain, but because it required direct brain injection in anesthetized rats, it isn’t a usable protocol for humans. Biohackers currently have no practical method to apply this finding for hydration or performance purposes.
Summary
In a rat study, giving kisspeptin-10 directly into the brain stopped the usual increase in urine and salt loss that happens when blood volume is suddenly raised. This was linked to higher levels of the hormone vasopressin, but not to changes in another hormone (ANP) or kidney nerve signals. The findings are interesting for science but don’t give a clear way for people to use kisspeptin for fluid balance in everyday life.
Abstract
To investigate the possible role of hypothalamic kisspeptin in the regulation of body fluid metabolism and maintenance of internal homeostasis. Natriuresis and diuresis were induced by blood volume expansion (VE) in anesthetized male rats and kisspeptin-10 was intracerebroventricularly (icv) administered. Radioimmunoassay (RIA) was used to measure the plasma arginine vasopressin (AVP) and atrial natriuretic peptide (ANP) concentrations during the VE. The mediation of the renal sympathetic nerve was also investigated in rats with bilateral renal sympathetic denervation. The increased urine flow and sodium excretion induced by VE were significantly inhibited by icv injection of 5 nmol kisspeptin-10 (P<0.05), which peaked 20 min after the decrease in VE. The mean arterial blood pressure and heart rate did not change during the experiment. Plasma AVP concentrations were significantly increased 20 min after icv injection of 5 nmol kisspeptin-10 during VE (P<0.05), while pretreatment with 5 nmol kisspeptin-10 did not significantly change plasma ANP concentrations. Furthermore, pretreatment with 5 nmol kisspeptin-10 could significantly inhibit VE-induced natriuresis and diuresis in renal sympathetic denervated rats (P<0.05). Central administration of kisspeptin-10 inhibited VE-induced natriuresis and diuresis. This effect was likely mediated by increasing AVP release independent of plasma ANP concentration and renal sympathetic nerve activity.
Study Information
pubmed
2009
2009-12-21T00:00:00.000Z
10.1038/aps.2009.179
14
18